Stay updated on Nivolumab in AML Prevention Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in AML Prevention Clinical Trial page.

Latest updates to the Nivolumab in AML Prevention Clinical Trial page
- CheckyesterdayChange DetectedThe study record’s latest update dates changed from November 13 and 11, 2026, to November 18 and 16, 2026. The website revision advanced from v3.8.0 to v3.8.1.SummaryDifference0.1%

- Check8 days agoChange DetectedThe study record’s update dates changed, reflecting a newer record submission and posting.SummaryDifference0.1%

- Check15 days agoChange DetectedThe NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” and related updates is no longer displayed at the top of the page.SummaryDifference1%

- Check22 days agoChange DetectedThe site footer revision changes from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check29 days agoChange DetectedA banner was added announcing an NIH terminology transition from “Artificial Intelligence” to “Super Intelligence.” The study record content remains unavailable behind a 403 error.SummaryDifference1%

- Check36 days agoChange DetectedThe site revision identifier in the footer changes from v3.7.1 to v3.7.2 on the 403 Forbidden page.SummaryDifference0.2%

Stay in the know with updates to Nivolumab in AML Prevention Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in AML Prevention Clinical Trial page.